Brian Hie

Brian Hie is an American computational biologist and assistant professor of chemical engineering at Stanford University, where he also serves as an Innovation Investigator at the Arc Institute. He leads the Laboratory of Evolutionary Design, a research group focused on applying artificial intelligence to biology, particularly through protein language models and generative AI for genome design. Hie is best known for developing Evo 2, an AI model that can write entire genomes, and for leading the team that created the first AI-generated viruses never found in nature.

His work sits at the intersection of computer science, chemical engineering, and biology, with a mission of developing biological AI for human good. Hie's research has attracted global attention for its potential to design new medicines, including bacteriophages that could kill harmful bacteria like E. coli. He is recognized as one of the leading young scientists in his field, with publications in top journals such as Nature. [edit]

Brian Hie's early life remains largely private, but his academic path reveals a deep interest in computing and biology. He earned a bachelor's degree in computer science, then pursued a PhD, completing it between 2017 and 2021. His doctoral research focused on machine learning approaches to biology, particularly protein language models and the language of viral evolution and escape.

During his PhD, Hie developed computational methods to understand biological sequences, laying the groundwork for his later breakthroughs in generative genome design. His early work involved using deep learning to interpret the language of entire genomes, a precursor to Evo 2. After completing his doctorate, he joined Stanford University as an assistant professor in January 2024, moving quickly to establish his own lab. [edit]

Brian Hie's breakthrough came in 2026 with the development of Evo 2, an AI model capable of writing whole genomes. In March 2026, his team published the Evo 2 research in Nature, demonstrating genome modelling across all domains of life. The paper, titled "Genome modelling and design across all domains of life with Evo 2," showcased the model's ability to generate functional DNA sequences.

In August 2026, Hie's team at Stanford and the Arc Institute used Evo 2 to design 16 entirely novel, self-replicating viruses never before found in nature, a world first. The viruses were synthesized in the lab based on AI-designed genomes. This achievement sparked international media coverage, with the BBC and The Guardian reporting on the breakthrough and its biosecurity implications. The research offers promise for new medicines, particularly in designing bacteriophages to kill bacteria like E. coli.

Hie is also connected to Genyro, a company that licensed Caltech's Sidewinder technology for complex DNA writing at scale, indicating his involvement in translating research into practical applications. [edit]

Brian Hie's public image is that of a serious, pioneering scientist at the forefront of AI-driven biology. Media coverage portrays him as a leader in a field with profound implications for medicine and biosecurity. His research content is technical and academic, published in Nature and presented at Stanford.

There is no documented fandom name or fan culture associated with him; his audience consists primarily of the scientific community and tech-media followers interested in AI and biology. He maintains an active presence on X (formerly Twitter) under the handle @BrianHie, where he shares updates on his work and engages with the AI-biology community. [edit]

Brian Hie's public following is rooted in the scientific community rather than in traditional fan culture. There is no formal fandom name, no fan campaigns, and no documented rituals or inside jokes. His audience consists primarily of researchers, students, and technology enthusiasts who follow his work through academic channels, his X account (@BrianHie), and his GitHub repositories. This is a following built on intellectual engagement, not celebrity adoration.

In the global landscape of fame, iFANN's Global Fame Engine has evaluated Brian Hie but has not placed him in its published rankings. As of August 2026, he holds no position in the Global Top 1,000 or any Top-100 scope list. This absence reflects the nature of his renown, which is substantial within specialized fields but not yet translated into the broad, cross-demographic recognition that drives high fame rankings. His visibility spiked dramatically in August 2026 with the international coverage of his team's creation of the first AI-designed viruses, a story that appeared in The Guardian, BBC, Financial Times, and Washington Post, but such media moments have not yet shifted his global fame placement.

His fame remains that of a pioneering scientist, significant and respected, but not yet ranked by iFANN's metrics.[edit]

Brian Hie's research group is named the Laboratory of Evolutionary Design, a nod to his focus on using AI to understand and engineer biological evolution. He is known for developing deep learning models that interpret the language of entire genomes, treating DNA sequences as a language to be learned. Hie's Evo 2 model is capable of writing whole genomes, not just reading them, a significant leap in generative AI for biology. The AI-designed viruses represent the first time generative AI has produced fully functional, self-replicating biological entities. He is affiliated with both Stanford University and the Arc Institute, a biomedical research organization. Hie maintains an active GitHub account with 37 repositories related to AI for biology and evo-design, sharing his work openly with the scientific community.

In August 2026, Hie's team at Stanford used Evo 2 to design a novel bacteriophage capable of killing E. coli, marking the first AI-generated virus ever created. This breakthrough was widely covered by major international outlets, including The Guardian, BBC, Financial Times, and Washington Post, and triggered significant public and scientific debate about AI safety and synthetic biology. The story became a defining moment in his career, transforming him from a niche academic into a central figure in the global conversation about AI's role in biology.[edit]

Details about Brian Hie's family, including parents, siblings, and his own household, are not publicly documented. He maintains a professional public profile focused on his scientific work, and no credible sources provide information about his personal life or family background.

Given the lack of public information, it is not possible to describe his family life in detail. [edit]

Brian Hie is associated with Aditi Merchant, a colleague who appears alongside him examining protein structures generated by Evo 2. His collaborators include researchers at Stanford University and the Arc Institute. [edit]

No public information is available regarding Brian Hie's dating history, romantic relationships, marital status, or children. He maintains a professional public profile focused on his scientific work, and no credible sources document any personal relationships. As of 2026, his relationship status is not publicly reported. [edit]

As an academic researcher, Brian Hie's net worth is not publicly documented. His income derives from his university salary as an assistant professor, research grants, and potentially equity or advisory roles in AI-biology companies such as Genyro. Given the lack of public financial disclosures, it is not possible to provide a specific figure from public records. iFANN currently estimates his net worth to be $1 Million, based on typical academic salaries and early-stage startup involvement.[edit]